Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-09

Clinical Trial Update: A Nasal Spray With Glucose Oxidase as a Treatment of Common Cold [Phase 2]

View source ↗

Summary

Phase 2 trial of a glucose oxidase nasal spray for the common cold has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucose Oxidase Nasal Spray (glucose oxidase nasal spray)

Snippet

Sponsor: Umeå University | Conditions: Common Cold | Phase 2 | Status: COMPLETED | Results posted: 2015-11-09